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To the Editor, 
Findings suggest a potential role for substance P 
(SP) in the gingival tissues, and in particular in the 
resident fibroblastic cells and a relationship between 
the neuropeptide release and neurogenic inflammation 
(1). SP is produced in a subset of capsaicin-sensitive 
sensory peripheral neuron cell bodies localized in the 
dorsal root and trigeminal ganglia (2), and plays an 
essential role in the transmission of noxious stimuli 
in the spinal cord. The stimulation of capsaicin-
sensitive sensory peripheral terminal of the 
neurons results in the peripheral release of several 
neuropeptides including SP (3, 4, 5), and evidence 
supports in particular a role of SP in the development 
and maintenance of dental pain and inflammation 
(6). Previous findings have demonstrated how SP 
The aim of this study was to evaluate substance P (SP) levels and the effect of a non-steroidal anti-
inflammatory drug (NSAID), ketoprofen, on SP in the pericoronal gingival tissue after extraction of 
upper third molars. A sample of 20 young non-smoking systemically healthy adults of both sexes, with a 
healthy upper third molar to extract for orthodontic purposes, was selected. After extraction, a sample 
of the gingival tissue of the pericoronal region was collected with a sterile scalpel, placed into test tubes 
and kept frozen at -20°C until the SP determination. SP levels were determined by using a commercially 
available enzyme immunoassay (ELISA) kit. The subjects were randomly divided into two groups: 
group 1 received a single dose of ketoprofen 30 minutes prior to the experimental procedure. The 
subjects of group 2 did not receive any kind of drug administration before extraction. The patients 
were asked to complete a diary on the postoperative pain. A relevant amount of SP was measured in all 
the gingival samples. No statistically significant difference could be detected in SP expression between 
the two groups. In group 1 pain appearance was significantly delayed (6.2±0.13 hours) in comparison 
with group 2 (3.95±0.2 hours). In this small selected group of subjects and limited study design, 
preventive administration of ketoprofen did not significantly affect the gingival levels of SP, the clinical 
recommendation emerging is that of NSAID administration postoperatively but before pain appearance 
in order to optimize the management of pain of the patient.
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consent was obtained from each patient. The study 
was performed according to the recommendations 
regarding ethical issues in research with human 
tissues of the University of Insubria of Varese, 
Italy, and was conducted in accordance with 
the Declaration of Helsinki. The subjects were 
randomly divided into two groups: group 1 received 
a single dose of 80 mg ketoprofen lysine salt (Oki® 
manufactured by Dompe CPA, Italy) in the form 
of sachet to dissolve in water, 30 min prior to the 
experimental procedure. The subjects of group 2 
did not receive any kind of drug administration. 
Prior to extraction the teeth were anaesthetized (1.8 
mL of 4% articaine with 1:100.000 epinephrine by 
infiltration injection); 15 min later a sample of the 
gingival tissue from the pericoronal region of the 
extraction site was collected with a sterile scalpel 
and placed into a test tube and kept at -20°C until 
the SP expression. The wound was then sutured 
and the patient was asked to complete a diary on 
the postoperative pain until the control appointment 
seven days later, in which time of appearance and 
recurrence of pain, necessity of use ketoprofen, and 
efficacy of the drug in controlling pain were analysed. 
A verbal pain intensity scale was used, where pain 
intensity was indicated as: no pain, slight, moderate, 
intense, severe (16).  Before surgery, the patients 
were carefully instructed on the compilation of the 
diary, and were further interviewed at the control 
appointment about the modalities of compilation 
in order to check the effectiveness of pain records. 
For SP determination, gingival samples were 
weighed and 0.5 ml of Acetic Acid 0.5N, containing 
a protease inhibitor cocktail (Roche, Milano, Italy), 
was added to all samples which were then boiled for 
10 min. Sample were homogenized and centrifuged 
at 10,000 x g for 10 min at 4°C. Supernatants were 
collected, dried with a Speed Vacuum Concentrator 
and resuspended in 0.3 ml of assay buffer. SP levels 
were determined by using a commercially available 
enzyme immunoassay (ELISA) kit according to 
the manufacturer’s instructions (R&D system, 
Milano, Italy). Sensitivity of the kit was 15 pg/ml. 
Non-parametric Mann-Whitney U test was used to 
analyse differences in pain duration and in SP levels 
since normality test failed.
represents a key neuropeptide in the generation of 
neurogenic inflammation as in presence of caries 
(7), occlusal trauma (8), after cavity preparation 
(9), dentin-bonding agent application (10), after the 
application of tooth bleaching products (11) and in 
orthodontic movements (12). Several studies have 
shown that SP expression is significantly increased 
in the inflamed pulp, suggesting that SP plays a key 
role in the pulpal inflammatory process (13).
Non-steroidal anti-inflammatory drugs (NSAIDs) 
are medications used frequently all over the world. 
NSAIDs may adequately control postoperative 
symptoms after different dental procedures such 
as the removal of third molars. Effective analgesia 
provides the patient with a better quality of life in 
the postoperative period, allowing faster recovery 
and earlier return to their daily activities. Common 
forms of postoperative pain prevention include the 
preoperative administration of NSAIDs (14, 15). The 
degree of nociception of patients seems to be related 
in part to the concentration of histamine, kinines, 
and prostaglandins at the site of inflammation. The 
maximum concentration of prostaglandins in acute 
tissue injuries occurs simultaneously with the peak 
of postoperative pain intensity (3 to 4 hours after 
injury). NSAIDs are capable of limiting peripheral 
sensitization by reducing prostaglandin synthesis 
at the site of surgery, however, few studies have 
evaluated the role of NSAID administration on 
neurogenic inflammation (13). This study aimed to 
measure SP expression in the gingival tissue after 
third molar extraction and to evaluate the effect 
of preoperative ketoprofen administration, a non-
steroidal anti-inflammatory drug (NSAID), on the 
quantity of SP in this tissue and on the degree of 
nociception of the patients.
MATERIALS AND METHODS
A sample of 20 (19-30 years old) systemically 
non-smoking healthy adults of both sexes was 
selected among the patients of the Department of 
Orthodontics of the University of Insubria, Varese, 
Italy. Inclusion criteria comprehended the presence 
of a healthy upper third molar programmed for 
extraction for orthodontic purposes. Written informed 
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test), as reported in Table III. Half of the patients in 
group 1 felt the necessity to take a second ketoprofen 
dose after tooth extraction, while in group 2 all the 
patients decided to take the drug at the appearance of 
pain after the surgical procedure. 
DISCUSSION
This study investigated the expression of SP and the 
effect of ketoprofen administration, a commonly 
used non-steroidal anti-inflammatory drug (NSAID), 
on the quantity of SP in the gingival tissue after 
upper third molar extraction. In the patients of group 
1 a single dose of ketoprofen lysine salt (“Oki”, 
Dompe CPA, Italy) was administered 30 minutes 
prior to extraction while in group 2 no drug was 
administered before the procedure. No statistically 
significant difference in SP expression could be 
detected between the two groups.
Caviedes and coworkers (17) reported an SP 
concentration of 0.453 pmol per mg of periodontal 
ligament of intact teeth; SP levels have also been 
RESULTS
A relevant amount of SP was measured in all the 
gingival samples. SP concentrations, expressed as 
pg/mg of tissue of each patient are reported in Tables 
I and II. As reported in Table III, no statistically 
significant difference was present in SP levels between 
the two groups. In Tables I and II also appearance of 
pain after extraction (expressed in hours), intensity 
of pain (classified by patients according to: no pain; 
slight; moderate; intense), time of reduction of pain 
after ketoprofen intake (expressed in minutes) for 
the patients who felt the necessity to take it, and 
the duration of pain relief (expressed in hours) are 
reported. Generally, patients experienced only slight-
to-moderate pain, and only one patient described pain 
as intense.
In group 1, appearance of pain was significantly 
delayed (6.2±0.13 hours) in comparison to patients 
who did not receive ketoprofen before the experimental 
procedure (3.95±0.2 hours). This difference resulted 
statistically significant (p< 0.0001, Mann-Whitney U 
Table I. Substance P and pain evaluation after tooth extraction of upper third molars,
in patients with ketoprofen administration 30 minutes before the procedure.
Patients group 1 SP pg/mg gingiva
Appearance of 
pain (hours after 
extraction)
Intensity of pain
Onset to pain 
relief (minutes 
after second 
ketoprofen intake)
Duration of pain 
relief (hours)
1 14.03 7 slight no drug
2 147.17 6 moderate 30 > 5
3 39.1 6 moderate 30 > 5
4 18.61 6 slight no drug
5 77.72 7 slight 30 > 5
6 42.8 6 slight no drug
7 32.87 6 moderate no drug
8 15.24 6 moderate 30 4 - 5
9 43.62 6 slight no drug
10 21.99 6 moderate 30 3 - 4
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previous study evaluating SP levels in the pulp after 
induced lesion (13).
The data of the present study are in accordance 
with evidence (14) suggesting that there seem to 
be no basis for pre-emptive analgesia with various 
NSAIDs in the third-molar surgical model. No 
prevention of postoperative pain was here reported, 
the only modification was a significantly postponed 
appearance of pain after tooth extraction with 
preventive ketoprofen administration (6.2±0.13 hours 
vs 3.95±0.2 hours). According to Kaczmarzyk and 
coworkers (19) ketoprofen was most effective when 
administered in the postoperative period. Liporaci 
Junior (20) showed no significant difference using 
ketoprofen for pre-emptive analgesia in surgical 
extraction of third molars. According to the data of 
this preliminary study, 5 patients of 10 of group 1 
investigated in the pulp and in the gingival crevicular 
fluid, however, no data is available on the pericoronal 
gingival tissues. The presence of increased SP levels 
could open new directions for treating inflammation 
and pain occurring after oral surgical procedures. 
In this study, considered preliminary due to the 
limited number of patients, Ketoprofen did not seem 
to interfere significantly on the SP expression in 
the pericoronal tissues after third molar extraction. 
Considering the efficacy of this molecule in the 
modulation of pain and inflammation in third molar 
surgery previously reported (18), this result may 
appear rather disappointing and could be interpreted 
as inability of the drug to prevent SP increase 
during surgical procedures even if the capacity to 
produce analgesia in the postoperative period is 
widely reported. These data are in accordance with a 
Table II. Substance P and pain evaluation after tooth extraction of upper third molars in patients with no drug 
administration before the procedure.
Patients group 2 SP pg/mg gingiva
Appearance of 
pain (hours after 
extraction)
Intensity of pain
Onset to pain 
relief (minutes 
after ketoprofen 
intake)
Duration of pain 
relief (hours)
1 40.99 3 moderate 30 > 5
2 43 4.5 slight 30 > 5
3 36 4 moderate 30 3 - 4
4 89.67 5 moderate 30 4 - 5
5 14.26 5 slight 30 > 5
6 33.80 3 slight 30 3 - 4
7 46.44 4 moderate 30 > 5
8 10.69 3.5 slight 30 > 5
9 19.35 3.5 slight 30 3 - 4
10 52.0 4 intense 30 4 - 5
Table III. Pericoronal Substance P levels and time to appearance of pain.
Group 1 (ketoprofen) Group 2 (no drug) Mann-Whitney U test
Gingival SP (pg/mg tissue) 
(mean±SEM)
45.31±12.81 38.62±7.18 p= 0.9
Appearance of pain (hours) 
(mean±SEM)
6.2±0.13 3.95±0.23 p< 0.0001
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R, Garcia DJ, Solano J,  Diaz E, Munoz HR. The effect 
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18. Pouchain EC, Costa FW, Bezerra TP,  Soares EC. 
Comparative efficacy of nimesulide and ketoprofen 
on inflammatory events in third molar surgery: a split-
used the drug also postoperatively, 5 patients of 10 
of group 2 took more than one dose of ketoprofen, so 
pre-emptive administration did not seem to result in 
reduction of pain and of quantity of painkillers used 
in the postoperative period. 
In conclusion, ketoprofen does not seem to interfere 
significantly on the SP expression in the pericoronal 
tissues after third molar extraction. Considering 
the efficacy of this molecule in the modulation of 
pain and inflammation in third molar surgery this 
result could be interpreted as inability of the drug to 
modulate SP during surgical procedures even if the 
capacity to produce analgesia in the postoperative 
period is widely reported. More studies with other 
molecules and performed on larger samples are 
necessary to evaluate the effect of NSAIDs on SP 
expression in the gingival tissues. In this small, 
selected group of subjects and limited study design 
the clinical recommendation that seems to emerge 
is that of NSAID administration postoperatively 
but before pain appearance in order to optimize the 
management of the postoperative pain of the patient.
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